Acasă › Melanom › North Carolina › Durham
Studii clinice pentru Melanom în Durham, NC
21 studii pentru Melanom caută participanți în și în jurul orașului Durham (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Durham VA Medical Center, Durham
NeoAdjuvant, Spare-Adjuvant (NASA) in Stage IIIB-IV (M1a) Melanoma
În curs de recrutareFaza 2
- Lineberger Comprehensive Cancer Center, Chapel Hill · La 10 mi distanță
DESTINY-PANTUMOUR04
În curs de recrutareStudiu observațional
- Research Site, Durham
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
În curs de recrutareFaza 3
- Duke Health System, Durham
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
În curs de recrutareFaza 3
- Duke University Medical Center, Durham
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
În curs de recrutareFaza 2
- Local Institution - 0100, Durham
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
În curs de recrutareStudiu observațional
- UNC- Chapel Hill, Chapel Hill · La 10 mi distanță
DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
În curs de recrutareFaza 1/2
- University of North Carolina, Chapel Hill · La 10 mi distanță
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
În curs de recrutareFaza 1/2
- Duke Cancer Institute, Durham
Project: Every Child for Younger Patients With Cancer
În curs de recrutareStudiu observațional
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · La 10 mi distanță
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
În curs de recrutareFaza 1
- Lineberger Comprehensive Cancer Center, Chapel Hill · La 10 mi distanță
A Feasibility Study Utilizing Immune Recall to Increase Response to Checkpoint Therapy
În curs de recrutareFaza 1
- Duke University Medical Center, Durham
A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel
În curs de recrutareFaza 1/2
- UNC Hospitals, The University of North Carolina at Chapel Hill, Chapel Hill · La 10 mi distanță
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
În curs de recrutareFaza 1/2
- Duke University Medical Center, Durham
IL-17 Blockade to Decrease irAEs (REPLAY)
În curs de recrutareFaza 1
- Duke University Health System, Durham
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
În curs de recrutareFaza 1/2
- University of North Carolina at Chapel Hill, Chapel Hill · La 10 mi distanță
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
În curs de recrutareFaza 2/3
- Duke University Medical Center, Durham
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
În curs de recrutareFaza 3
- Duke University Medical Center - Duke Cancer Center, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, Chapel Hill · La 10 mi distanță
Excision of Lymph Node Trial (EXCILYNT) (Mel69)
În curs de recrutare
- Duke University Health System, Durham
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
În curs de recrutare
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · La 10 mi distanță
- University of North Carolina Hospitals - Hillsborough Campus, Hillsborough · La 13 mi distanță
Studii pentru Melanom în alte orașe
- Houston, TX59 studii
- New York City, NY38 studii
- Los Angeles, CA34 studii
- Nashville, TN33 studii
- Pittsburgh, PA31 studii
- Boston, MA26 studii
- Philadelphia, PA23 studii
- San Francisco, CA22 studii
- Atlanta, GA21 studii
- St. Louis, MO21 studii
- Salt Lake City, UT21 studii
- Columbus, OH21 studii
Alte studii în Durham
- Cancer de sân63 studii
- Cancer (toate tipurile)58 studii
- Cancer pulmonar cu celule non-pătrate39 studii
- Mielom multiplu37 studii
- Cancer metastatic33 studii
- Leucemie mieloasă acută33 studii
- Cancer pulmonar32 studii
- Cancer de prostată32 studii
- Cancer colorectal28 studii
- Leucemie limfatică cronică27 studii
- Cancer ovarian27 studii
- Insuficiență cardiacă26 studii
Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.